| Deng, Chao |
NCT05433480: A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer |
|
|
| Active, not recruiting | 3 | 274 | RoW | BPI-16350, placebo, Fulvestrant | Betta Pharmaceuticals Co., Ltd. | Breast Cancer | 12/23 | 07/25 | | |
NCT06527300: A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents With Advanced NUT Cancer |
|
|
| Recruiting | 2 | 48 | RoW | NHWD-870 HCl | Zhejiang Wenda Medical Technology Co., Ltd. | Patients With Advanced NUT Cancer | 06/25 | 12/25 | | |
NCT05872347: Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases. |
|
|
| Recruiting | 2 | 52 | RoW | SPH4336 Tablets | Shanghai Pharmaceuticals Holding Co., Ltd | Breast Cancer Brain Metastases | 12/25 | 12/25 | | |
NCT05470452: Validating the Safety and Effectiveness of ENDOANGEL Upper Gastrointestinal Endoscope Image Auxiliary Diagnostic Software |
|
|
| Recruiting | N/A | 340 | RoW | The reading process is assisted by ENDOANGEL, No ENDOANGEL assistance during the reading process | The Second Affiliated Hospital of Chongqing Medical University | Gastric Cancer | 08/22 | 08/22 | | |
